CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 182373-182485 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"She was changed to a different IVIG product with a higher IgA content with complete improvement of her symptoms.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T62619","span":{"begin":0,"end":112},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T62619","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T343","span":{"begin":0,"end":112},"obj":"Sentence"}],"attributes":[{"subj":"T343","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1628","span":{"begin":4,"end":7},"obj":"Disease"}],"attributes":[{"id":"A1628","pred":"mondo_id","subj":"T1628","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T1628","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93eca3","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec939c"},{"id":"CORD-19-PD-MONDO","color":"#93b6ec"}]}]}}